Understanding and Treating Blood Cancers
Official title: Hematologic Malignancies
Funded at Stanford University · NIH-11099849 · Data updated 2026-11-12
This program aims to better understand blood cancers like leukemia and lymphoma to find new ways to diagnose and treat them.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project start | June 4, 2007 |
| Project end | May 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $169,872 |
| NIH project number | 5P30CA124435-17 |
| Project ID | NIH-11099849 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with blood cancers such as Acute Myeloid Leukemia (AML) and B-Cell Chronic Lymphocytic Leukemia (CLL) are the focus of this research.
✕Less likely to help
Patients without a diagnosis of hematologic malignancies would not directly benefit from this specific research program.
What this research studies
Our program brings together experts from various fields to explore the causes of blood cancers, identify markers that help monitor the disease, and develop new treatments. We focus on translating discoveries from the lab directly to patient care, and also learn from patient samples to guide our laboratory work. This collaborative approach helps us make progress in diagnosing and treating complex blood disorders, with a strong emphasis on moving new ideas into clinical practice. Our team has a history of leading clinical trials that have resulted in new FDA-approved therapies.
Why it matters
Potential benefit: If successful, this program could lead to improved diagnostic tools and new, more effective therapies for patients with various blood cancers.
How similar studies have gone: This program builds on a strong history of translational research, with members having led clinical trials that resulted in several FDA-approved therapies.
Where this research is happening
-
Stanford University
Stanford, United States Active
Researchers
- Principal investigator: Levy, Ronald — Stanford University
- Study coordinator: Levy, Ronald
Related research
Other NIH-funded projects on the same topics.
-
Adapting flow cytometry to detect childhood leukemias in Kenya using a single-test screen
A low-cost, blood-based flow cytometry screen in Kenya aims to detect and triage suspected leukemias in children and young adults.
-
Understanding why patients with blood cancers start and stick with oral cancer medicines
A study to learn what helps or hinders Black patients with blood cancers in starting and continuing their prescribed oral cancer medicines.
-
Why some blood cancer cells survive after treatment by resisting natural killer cells
This work is trying to understand why leftover blood cancer cells in leukemia and multiple myeloma survive treatment by escaping natural killer immune cells.
-
Expanding blood cancer care and research to Brooklyn and Queens
Aimed at bringing more blood cancer care and clinical trials to Brooklyn and Queens to help a diverse patient community.
-
Adapting flow cytometry to detect blood cancers in Kenyan children and young people
A nationwide Kenyan effort will test a cheaper, single-blood-sample screening method using flow cytometry to screen for leukemia in kids and young adults who may have the disease.
-
Next-gen genetic engineering of CD45 to boost CAR-T therapy for blood cancers
A research team is developing a way to make CAR-T cells work for many blood cancers by re-engineering a common blood cell protein called CD45.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.